MBI Share Price

Open 0.04 Change Price %
High 0.04 1 Day -0.01 -25.00
Low 0.03 1 Week -0.01 -25.00
Close 0.03 1 Month -0.01 -25.00
Volume 179000 1 Year -0.02 -40.00
52 Week High 0.09
52 Week Low 0.03
MBI Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.03
Support 1 0.02
Support 2 0.02
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
BVQ 0.02 100.00%
CQR 0.02 100.00%
CQR 0.02 100.00%
BOR 0.02 100.00%
BOR 0.02 100.00%
BOR 0.02 100.00%
BOR 0.02 100.00%
WRP 0.02 100.00%
FTI 0.06 100.00%
FTI 0.06 100.00%
More..
CVE Canada Top Losers Stocks
EEV 0.00 -100.00%
MXM 0.00 -100.00%
MXM 0.00 -100.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Med Biogene Inc (CVE: MBI)

MBI Technical Analysis 5
As on 5th Dec 2016 MBI Share Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.06 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
MBI Target for December
1st Target up-side 0.05
2nd Target up-side 0.05
3rd Target up-side 0.05
1st Target down-side 0.03
2nd Target down-side 0.03
3rd Target down-side 0.03
MBI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.medbiogene.com
MBI Address
MBI
580 Hornby Street
Suite 510
Vancouver, BC V6C 3B6
Canada
Phone: 800-641-3593
Fax: 888-646-2531
Interactive Technical Analysis Chart Med Biogene Inc ( MBI CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Med Biogene Inc
MBI Business Profile
Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient’s tumor to provide information to assist in tailoring treatment for that specific patient. The company has a collaboration agreement with the University Health Network. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.